During the past decade, Central Sydney Dermatology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Sydney Dermatology" #1 collaborator was "Celtaxsys Aus Pty Limited" with 1 trials as a collaborator and "Clinical Network Services (CNS) Pty Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Central Sydney Dermatology" are "Acne Vulgaris" (1 trials) and "Masseter Muscle Hypertrophy" (1 trials). Many other conditions were trialed in "Central Sydney Dermatology" in a lesser frequency.

Most popular intervention types in "Central Sydney Dermatology" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "CTX-4430" (1 trials), "Normal saline" (1 trials), "Placebo" (1 trials) and "botulinum toxin Type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Sydney Dermatology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Central Sydney Dermatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Central Sydney Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central Sydney Dermatology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".